15 reports of this reaction
3.5% of all ARTICAINE HYDROCHLORIDE AND EPINEPHRINE reports
#2 most reported adverse reaction
HYPOXIA is the #2 most commonly reported adverse reaction for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, manufactured by Benco Dental. There are 15 FDA adverse event reports linking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE to HYPOXIA. This represents approximately 3.5% of all 433 adverse event reports for this drug.
Patients taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE who experience hypoxia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HYPOXIA is moderately reported among ARTICAINE HYDROCHLORIDE AND EPINEPHRINE users, representing a notable but not dominant share of adverse events.
In addition to hypoxia, the following adverse reactions have been reported for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE:
The following drugs have also been linked to hypoxia in FDA adverse event reports:
HYPOXIA has been reported as an adverse event in 15 FDA reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HYPOXIA accounts for approximately 3.5% of all adverse event reports for ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, making it one of the most commonly reported side effect.
If you experience hypoxia while taking ARTICAINE HYDROCHLORIDE AND EPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.